Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Purpose: To improve treatment efficacy and tumor cell selectivity of δ-aminolevulinic acid (ALA)-based photodynamic therapy (PDT) via pretreatment of cells and tumors with methotrexate to enhance intracellular photosensitizer levels. Experimental Design: Skin carcinoma cells, in vitro and in vivo, served as the model system. Cultured human SCC13 and HEK1 cells, normal keratinocytes, and in vivo skin tumor models were preconditioned with methotrexate for 72 h and then incubated with ALA for 4 h. Changes in protoporphyrin IX (PpIX) levels and cell survival after light exposure were assessed. Results: Methotrexate preconditioning of monolayer cultures preferentially increased intracellular PpIX levels 2- to 4-fold in carcinoma cells versus normal keratinocytes. Photodynamic killing was synergistically enhanced by the combined therapy compared with PDT alone. Methotrexate enhancement of PpIX levels was achieved over a broad methotrexate concentration range (0.0003-1.0 mg/L; 0.6 nmol/L-2 mmol/L). PpIX enhancement correlated with changes in protein expression of key porphyrin pathway enzymes, ∼4-fold increase in coproporphyrinogen oxidase and stable or slightly decreased expression of ferrochelatase. Differentiation markers (E-cadherin, involucrin, and filaggrin) were also selectively induced by methotrexate in carcinoma cells. In vivo relevance was established by showing that methotrexate preconditioning enhances PpIX accumulation in three models: (a) organotypic cultures of immortalized keratinocytes, (b) chemically induced skin tumors in mice; and (c) human A431 squamous cell tumors implanted subcutaneously in mice. Conclusion: Combination therapy using short-term exposure to low-dose methotrexate followed by ALA-PDT should be further investigated as a new combination modality to enhance efficacy and selectivity of PDT for epithelial carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy with endogenous protoporphyrin
Kennedy, J. C., Pottier, R. H., & Pross, D. C. (1990) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(90)85083-9 · Cited by 1,509
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin
Iinuma, S., Farshi, S., Ortel, B., & Hasan, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.244 · Cited by 240
Self-citationPeng, Q., Soler, A. M., Warloe, T., Nesland, J. M., & Giercksky, K.-E. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00173-7 · Cited by 218
Ohgari, Y., Nakayasu, Y., Kitajima, S., Sawamoto, M., Mori, H., Shimokawa, O., Matsui, H., & Taketani, S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.019 · Cited by 165
Sinha, A. K., Anand, S., Ortel, B. J., Chang, Y., Mai, Z., Hasan, T., & Maytin, E. V. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603273 · Cited by 114
Self-citationKondo, M., Hirota, N., Takaoka, T., & Kajiwara, M. (1993) · Cell Biology and Toxicology · doi:10.1007/bf00755143 · Cited by 69
Evaluation of the penetration of 5‐aminolevulinic acid through basal cell carcinoma: a pilot study
Ahmadi, S., McCarron, P. A., Donnelly, R. F., Woolfson, A. D., & McKenna, K. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00181.x · Cited by 55
Cited by
Mechanisms of Resistance to Photodynamic Therapy
Casas, A., Di Venosa, G., Hasan, T., & Batlle, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843272 · Cited by 322
Self-citationHyaluronan: More than just a wrinkle filler
Maytin, E. V. (2016) · Glycobiology · doi:10.1093/glycob/cww033 · Cited by 128
Self-citationde Souza, A. L. R., Marra, K., Gunn, J., Samkoe, K. S., Kanick, S. C., Davis, S. C., Chapman, M. S., Maytin, E. V., Hasan, T., & Pogue, B. W. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.267 · Cited by 51
Self-citationTakahashi, K., Ikeda, N., Nonoguchi, N., Kajimoto, Y., Miyatake, S.-I., Hagiya, Y., Ogura, S.-I., Nakagawa, H., Ishikawa, T., & Kuroiwa, T. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor116 · Cited by 46
“Similar results were also observed in skin cancer cell lines in vivo.(19) Although these in vitro experiments do not directly reflect the in vivo situations in brain tumor patients, such observations indirectly support the notion that the induction of CPOX gene expression is one of the key molecular mechanisms underly…”
ResultRetractedSpecific Inhibition of the ABCG2 Transporter Could Improve the Efficacy of Photodynamic Therapy
Bebes, A., Nagy, T., Bata-Csörgő, Z., Kemény, L., Dobozy, A., & Széll, M. (2011) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2011.08.007 · Cited by 28
“It has recently been reported that low-dose methotrexate enhances DALA-based PDT in skin carcinoma cells [2].”
Background
Metadata
- Authors
- Anand, S., Honari, G., Hasan, T., Elson, P., & Maytin, E. V.
- Venue
- Clinical Cancer Research
- Published
- 2009-05-15
- Volume
- 15
- Issue
- 10
- Pages
- 3333-3343
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2151262284
- Cited by
- 116
- References
- 7
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-08-3054
- The paper
- Anand, S., Honari, G., Hasan, T., Elson, P., & Maytin, E. V. (2009). Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-08-3054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.